Anúncio
Anúncio
PCVX
Vaxcyte, Inc. Common Stock
46.47
USDPatrocinado
+0.33
+0.72%
02 de jan., 15:59 UTC -5
Encerrado
Pós-Mercado
46.48
+0.01
+0.02%
Relatórios de Lucros PCVX
Rácio de surpresa positiva
PCVX separação 12 de 22 últimas estimativas.
55%
Próximo Relatório
Data do Próximo Relatório
23 de fev. de 2026
Estimate for Q4 25 (Revenue/ EPS)
--
/-$1.51
Mudanças implicadas de Q3 25 (Revenue/ EPS)
--
/-3.21%
Mudanças implicadas de Q4 24 (Revenue/ EPS)
--
/+49.50%
Vaxcyte, Inc. Common Stock earnings per share and revenue
On 04 de nov. de 2025, PCVX reported earnings of -1.56 USD per share (EPS) for Q3 25, missing the estimate of -1.29 USD, resulting in a -20.53% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference. The market reacted with a -2.49% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 12 analistas forecast an EPS of -1.51 USD, with revenue projected to reach -- USD, implying an diminuir of -3.21% EPS, and aumentar of 0.00% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
enGene Holdings Inc. Common Stock
Report Date
22 de dez. de 2025 Para Q4 25
Estimativa
-$0.57
Real
-$0.73
Surpresa
-25.95%
Citius Oncology, Inc. Common Stock
Report Date
23 de dez. de 2025 Para Q4 25
Estimativa
-$0.12
Real
-$0.06
Surpresa
+50.98%
FAQ
What were Vaxcyte, Inc. Common Stock's earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, Vaxcyte, Inc. Common Stock reported EPS of -$1.56, missing estimates by -20.53%, and revenue of $0.00, 0% as expectations.
How did the market react to Vaxcyte, Inc. Common Stock's Q3 2025 earnings?
The stock price moved down -2.49%, changed from $41.35 before the earnings release to $40.32 the day after.
When is Vaxcyte, Inc. Common Stock expected to report next?
The next earning report is scheduled for 23 de fev. de 2026.
What are the forecasts for Vaxcyte, Inc. Common Stock's next earnings report?
Based on 12
analistas, Vaxcyte, Inc. Common Stock is expected to report EPS of -$1.51 and revenue of -- for Q4 2025.
Which companies are reporting earnings today?
Verificar FXEmpire's Earnings Calendar for today's list of reporting companies.
Anúncio